#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelodysplastic syndrome SAPHO syndrome Spinal muscular atrophy Extranodal marginal zone B-cell lymphoma (MALT type) Albright's disease Oropharyngeal cancer recurrent Antithrombin III deficiency IPEX syndrome Brain abscess High-grade B-cell lymphoma Advanced systemic mastocytosis Acute on chronic liver failure Isodicentric chromosome 15 syndrome Pyruvate kinase deficiency anaemia Toxic epidermal necrolysis More trials…

    Learn about Rare Diseases

    MELAS syndrome – Diagnostics Leiomyosarcoma – Life with Disease Lymphatic malformation – Diagnostics Gaucher’s disease type I Marfan’s syndrome – Trials in Disease Gastrointestinal stromal tumour Cystic fibrosis – Diagnostics Metachromatic leukodystrophy Haemophilia B with anti factor IX Mucopolysaccharidosis III – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ibuprofen Lysine Tebipenem Pivoxil Hydrobromide Glibenclamide Vigabatrin Crinecerfont Eye103 Xp-Dc+Tl+Klh Aavanc80-3'Hotof Anhydrous Glucose Bp PEGZILARGINASE Ferric Carboxymaltose ANXV Botensilimab Glyceryl Trinitrate Dexrazoxane Folic Acid Bedaquiline Gskvx000000014593 Bevacizumab Zirconium Zr-89 Bt8009 More therapies…

    Learn about Your Condition

    Status epilepticus Malignant melanoma stage IV Endometrial cancer recurrent IgA nephropathy Malignant neoplasm of choroid Muscular dystrophy Epileptic encephalopathy Liver disorder Papilloma viral infection Subdural haematoma Stress Pneumonia bacterial Lymphangioma Endometrial cancer stage I Brain neoplasm malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Safety and Effectiveness of APG777 for Patients with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Apg777
    Czechia France Germany Hungary Poland Spain

  • Study on Blood Vessel Changes in Basal Cell Carcinoma Patients Treated with Bleomycin or Drug Combination

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Basal cell carcinoma
    Investigated Drugs:
    • Bleomycin
    Denmark

  • Study of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Skin bacterial infection
    Investigated Drugs:
    • Aztreonam
    • Oritavancin
    Bulgaria Greece Latvia Lithuania Poland Portugal +2

  • Study on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Guselkumab
    • Ustekinumab
    Denmark France Germany Italy The Netherlands Poland +1

  • Study on Methotrexate and Phototherapy for Adults with Progressive Vitiligo

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Microcrystalline Cellulose
    • Calcium Folinate
    • Methotrexate Sodium
    France

  • Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Ruxolitinib
    Belgium Bulgaria France Germany Hungary Italy +3
Previous Page
1 … 39 40 41 42 43 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!